<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01768481</url>
  </required_header>
  <id_info>
    <org_study_id>HMR</org_study_id>
    <nct_id>NCT01768481</nct_id>
  </id_info>
  <brief_title>Intima Media Thickness Regression in Dyslipidemic Teenagers</brief_title>
  <official_title>Intervention précoce Sur Les Indices d'athérogénèse Des Adolescents à Risque</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Montréal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Montréal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial of statin intervention in dyslipidemic obese teenagers. Primary
      outcome is intima media thickness before and after intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese teenagers with abnormal lipid profiles were randomized to either low dose statin or
      placebo and had their carotid intima media thickness compared before and after intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>carotid intima media thickness</measure>
    <time_frame>12 months</time_frame>
    <description>Carotid Intima media thickness measured at baseline and after 12 months in 2 arms (placebo and statin)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>weight</measure>
    <time_frame>12 months</time_frame>
    <description>weight, height and BMI recorded before and after intervention</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Lipid profile</measure>
    <time_frame>6 months</time_frame>
    <description>Complete lipid profile were recorded at baseline , 6 months and 12 months after intervention.</description>
  </other_outcome>
  <other_outcome>
    <measure>lipid profile</measure>
    <time_frame>12 months</time_frame>
    <description>Lipid profile measured at end of study</description>
  </other_outcome>
  <other_outcome>
    <measure>BMI</measure>
    <time_frame>12 months</time_frame>
    <description>BMI neasured at baseline and at end of study</description>
  </other_outcome>
  <other_outcome>
    <measure>liver functions</measure>
    <time_frame>3 months</time_frame>
    <description>ALT/AST done at 3, 6, 9 and 12 months</description>
  </other_outcome>
  <other_outcome>
    <measure>liver functions</measure>
    <time_frame>6 months</time_frame>
    <description>ALT/AST done at 3, 6, 9, and 12 months</description>
  </other_outcome>
  <other_outcome>
    <measure>liver functions</measure>
    <time_frame>9 months</time_frame>
    <description>ALT/AST done at 3, 6, 9, and 12 months</description>
  </other_outcome>
  <other_outcome>
    <measure>liver functions</measure>
    <time_frame>12 months</time_frame>
    <description>ALT/AST done at 3, 6, 9, and 12 months</description>
  </other_outcome>
  <other_outcome>
    <measure>creatinine kinase</measure>
    <time_frame>3 months</time_frame>
    <description>CK done at 3 , 6, 9 and 12 months</description>
  </other_outcome>
  <other_outcome>
    <measure>creatinine kinase</measure>
    <time_frame>6 months</time_frame>
    <description>CK done at 3 , 6, 9 and 12 months</description>
  </other_outcome>
  <other_outcome>
    <measure>creatinine kinase</measure>
    <time_frame>9 months</time_frame>
    <description>CK done at 3 , 6, 9 and 12 months</description>
  </other_outcome>
  <other_outcome>
    <measure>creatinine kinase</measure>
    <time_frame>12 months</time_frame>
    <description>CK done at 3 , 6, 9 and 12 months</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Obesity</condition>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>Statin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Atorvastatin 10 mg every day for one year</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Same size, taste and size placebo tablet (manufactured by sponsor) given every day for one year.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atorvastatin</intervention_name>
    <description>10 mg Atorvastatin vs placebo daily in a randomized controlled trial for one year</description>
    <arm_group_label>Statin</arm_group_label>
    <other_name>Statin</other_name>
    <other_name>Lipitor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sugar pill</intervention_name>
    <description>placebo controlled arm receives similarly looking placebo.</description>
    <arm_group_label>Sugar pill</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obesity

          -  Abnormal Triglyceride levels (&gt;1.7mmol/L).

          -  Abnormal HDL-C levels (1.0mmol/L)

        Exclusion Criteria:

          -  Abnormal thyroid unfction (not treated)

          -  Diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent Legault, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Maisonneuve-Rosemont, UMontreal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Maisonneuve-Rosemont</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2013</study_first_submitted>
  <study_first_submitted_qc>January 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2013</study_first_posted>
  <last_update_submitted>January 11, 2013</last_update_submitted>
  <last_update_submitted_qc>January 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Montréal</investigator_affiliation>
    <investigator_full_name>Laurent Legault</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>Intima media thickness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

